300 patients tracked to see if aortic stent holds up over time

NCT ID NCT06094127

Ongoing Knowledge-focused Sponsor: Cook Research Incorporated Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 300 people who already received a Zenith® Alpha Thoracic Endovascular Graft to treat a thoracic aortic aneurysm or ulcer. Researchers are checking how well the device works and how safe it is over the long term, especially looking at deaths related to the aortic disease. The goal is to gather real-world data to confirm the device's performance over its expected lifetime.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PENETRATING AORTIC ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm Penetrating Atherosclerotic Ulcer thoracic aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PENETRATING AORTIC ULCER THORACIC AORTIC ANEURYSM

Contacts and locations

Locations

CHU Dijon Bourgogne

Dijon, 21079, France
Centre Hospitalier Regional Universitaire de Lille

Lille, 59000, France
Hopital Marie Lannelongue Groupe Hospitalier Pairs St Joseph

Le Plessis-Robinson, 92350, France
IRCCS Ospedale San Raffaele

Milan, 20132, Italy
IRCCS-University Hospital Sant'Orsolo Polyclinic

Bologna, 40138, Italy
Maastricht University Medical Center

Maastricht, 6202 AZ, Netherlands
Radboud UMC

Nijmegen, 6500 HB, Netherlands
St. Franzikus Hospital Munster

Münster, 48145, Germany
Universitätsklinikum Hamburg-Eppendorf

Hamburg, 20246, Germany
Universitätsklinikum der LMU München

München, 81377, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.